Table 4.
Functional capacity and disability score in both groups for all three time-points excluding the dropouts.
| Variables | Placebo Group (n = 18) |
OMEGA Group (n = 18) |
Main Effects and Interactions (p Value) |
||
|---|---|---|---|---|---|
| Time | Time X Group | Group | |||
| Six Minute Walk Test Normalized (m) | |||||
| Baseline | 504 ± 131 | 505 ± 99 | 0.137 | 0.186 | 0.337 |
| 12 months | 523 ± 90 | 546 ± 73 | |||
| 24 months | 494 ± 79 | 551 ± 101 | |||
| STS5 (s) | |||||
| Baseline | 12.57 ± 3.52 | 12.37 ± 2.83 | 0.001 | 0.078 | 0.359 |
| 12 months | 10.67 ± 2.75 | 10.33 ± 2.26 | |||
| 24 months | 11.52 ± 1.97 | 9.91 ± 1.72 | |||
| STS 30 (rep) | |||||
| Baseline | 12.55 ± 2.97 | 12.44 ± 2.63 | 0.001 | 0.040 | 0.297 |
| 12 months | 14.66 ± 3.1 | 15.16 ± 2.66 | |||
| 24 months | 13.22 ± 2.18 | 15.22 ± 2.39 | |||
| STS60 (rep) | |||||
| Baseline | 25 ± 6.10 | 25.16 ± 5.51 | 0.001 | 0.032 | 0.279 |
| 12 months | 29.55 ± 6.20 | 30.33 ± 5.12 | |||
| 24 months | 26.22 ± 4.27 | 30.38 ± 4.86 | |||
| TUG (s) | |||||
| Baseline | 8.90 ± 1.76 | 8.21 ± 1.47 | 0.003 | 0.411 | 0.097 |
| 12 months | 8.04 ± 1.94 | 7.44 ± 1.84 | |||
| 24 months | 8.80 ± 1.61 | 7.63 ± 1.09 | |||
| EDSS | |||||
| Baseline | 2.36 ± 1.09 | 2.22 ± 1.08 | 0.001 | 0.001 | 0.446 |
| 12 months | 2.41 ± 1.10 | 2.27 ± 1.04 | |||
| 24 months | 2.83 ± 1.20 | 2.27 ± 1.04 | |||
Abbreviations: STS-5, sit-to-stand test 5-repetitions; STS-30, sit-to-stand test 30 s; STS-60, sit-to-stand test 60 s; TUG, timed up and go test; EDSS, Expanded Disability Scale Score. Data expressed as mean ± SD. Bold text indicates a statistically significant difference with a p-value less than 0.05.